Shinhan Life Launches Health Insurance Covering Outpatient Treatment Costs from Early Symptoms of Three Major Diseases

Shinhan Life announced on the 9th the launch of the 'Shinhan Life Amazing Health Insurance,' which covers everything from precursor diseases of cancer, cerebral hemorrhage (cerebral infarction), and acute myocardial infarction to outpatient treatment costs at tertiary general hospitals.

[Asia Economy Reporter Oh Hyung-gil] Shinhan Life announced on the 9th that it has launched the 'Shinhan Life Amazing Health Insurance,' which covers everything from precursor diseases of cancer, cerebral hemorrhage (cerebral infarction), and acute myocardial infarction to outpatient treatment costs at tertiary general hospitals.

The main contract features unlimited coverage of 50,000 KRW per visit for outpatient treatment after diagnosis of the three major diseases to monitor prognosis.

By subscribing to the cerebrovascular disease-specific precursor coverage rider, coverage of 500,000 to 1,000,000 KRW is provided for diagnosis benefits such as atherosclerosis, epilepsy, diabetes, and hypertension medication treatment benefits, allowing treatment management from the onset of cerebrovascular disease precursor symptoms.

It also covers sleep disorders and gastrointestinal diseases, which have recently shown a rapid increase in incidence. Through the sleep apnea coverage rider, surgery costs for specific sleep-related diseases, insured polysomnography test fees, and sleep apnea diagnosis benefits are covered. Additionally, by adding the specific gastrointestinal disease coverage rider, a diagnosis benefit is provided upon diagnosis of gastric ulcers and duodenal ulcers.

With 34 types of riders offering various coverages such as diagnosis fees, hospitalization fees, surgery fees, and death benefits, it is possible to design customized insurance optimized for the customer's age, health condition, and lifestyle. The subscription age is from 15 to 65 years old, and coverage extends up to 100 years old through renewals.

This content was produced with the assistance of AI translation services.